The new model aims to support better patient outcomes in Australian hospitals by strengthening leadership, culture, systems and accountability in clinical governance....
There is a growing tendency to seek a second opinion, especially in oncology, where treatment options may include surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy, or genetic profiling...
The designation supports Gene Solutions’ US development pathway for its multi-omic blood-based test designed to detect cancer-associated signals across 10 cancer types. ...
Open-access digital platform supports policymakers, researchers and the public in exploring the health, economic and education impacts of pandemic response strategies....
Peking University Shenzhen Hospital Team Shares Interim Evaluation Data from Urine-Based Cervical Cancer Screening Study...
RAMP UP programme with Hitachi High-Tech America supports electronic genome mapping studies in AML and MDS ...
This innovative test, originally developed by Memorial Sloan Kettering Cancer Centre in New York...
The launch of pTau217 marks a significant step in providing a simple, blood-based tool to diagnose Alzheimer's much earlier in the patient journey...
The FDA 510(k) clearance advances Biozen’s BP1000, a handheld fingertip device designed to deliver clinically validated spot blood pressure measurements without an arm cuff or per-user calibration. ...
The event highlighted healthcare AI’s shift from experimentation to real-world deployment, with discussions on accountability, governance, workforce readiness and exhibitor solutions including Heidi and AITRICS-VC....
